MONOD BIO
Monod Bio is a life sciences company developing biosensors for protein and other analyte detection. Its biosensor platform combines binding, transduction, and amplification to detect a range of target molecules. It utilizes recent advances in computational protein engineering to create highly modular bio-sensing nano switches that stimulate rapid, sensitive, and inexpensive analytical assays. Monod Bio was founded in 2021 and is headquartered in Seattle, Washington.
MONOD BIO
Social Links:
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2021-11-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.monod.bio
Total Employee:
1+
Status:
Active
Contact:
+1 206 822 1255
Total Funding:
25 M USD
Similar Organizations
Akarna Therapeutics
At Akarna, our mission is to develop best-Âin-Âclass treatments for NASH and other chronic liver diseases
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Dilyx Biotechnologies
Dilyx Biotechnologies offers protein solubility analysis kits.
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
Current Employees Featured
Founder
Investors List
Global Health Investment Fund (GHIF)
Global Health Investment Fund (GHIF) investment in Seed Round - Monod Bio
Matrix Capital Management
Matrix Capital Management investment in Seed Round - Monod Bio
Boom Capital
Boom Capital investment in Seed Round - Monod Bio
Washington Research Foundation
Washington Research Foundation investment in Seed Round - Monod Bio
Sahsen Ventures
Sahsen Ventures investment in Seed Round - Monod Bio
Cercano Management
Cercano Management investment in Seed Round - Monod Bio
Pack Ventures
Pack Ventures investment in Seed Round - Monod Bio
Official Site Inspections
http://www.monod.bio
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Monod Bio"
Monod Bio - AI-Powered Protein Design
Revolutionizing life sciences tools and clinical diagnostics.See details»
Monod Bio - Crunchbase Company Profile & Funding
Monod Bio is a life sciences company developing biosensors for protein and other analyte detection. Its biosensor platform combines binding, transduction, and amplification to detect a range of target molecules.See details»
Our Team - Monod Bio
We launched Monod Bio in 2022 as a spin-out from the Baker Lab at the University of Washington (UW) Institute for Protein Design (IPD). Since then, we are using AI-powered de novo protein design to create RUO tools and IVDs …See details»
Monod Bio Company Profile 2024: Valuation, Funding …
Developer of biosensors designed to detect proteins, toxins, antibodies and other molecules. The company's biosensor platform combines binding, transduction, and amplification in one step to detect a wide range of target molecules, …See details»
Monod Bio - LinkedIn
Monod Bio, a company co-founded by 2024 Nobel Laureate David Baker, is the first to commercialize protein products developed entirely through computational design as they don't occur naturally.See details»
Monod Bio Company Profile - Office Locations, Competitors
Monod Bio is a life sciences company developing a biosensor platform. It uses computational protein engineering to create modular biosensing nanoswitches for analytical assays. The …See details»
Biosensor startup Monod secures $25M seed financing
Aug 15, 2022 · Monod Bio, a life sciences company developing custom diagnostic biosensors that emit light to detect specific biomolecules of interest, today announced it has raised a $25M seed financing round.See details»
Biosensor startup Monod lands $6M and spins out of …
Dec 23, 2021 · Monod Bio is developing biosensors that can quickly detect viral proteins, toxins, antibodies, or other molecules. The sensors are built from engineered proteins developed at the IPD.See details»
Monod Bio, a David Baker lab spinout, gets $25 million for …
Aug 19, 2022 · Monod Bio, a diagnostic biosensor company spun out of David Baker’s lab at the University of Washington Institute for Protein Design, has raised $25 million in seed funding.See details»
Monod Bio Closes $25M Seed Financing to Advance …
Aug 15, 2022 · Monod is using state-of-the-art computational protein design to develop a new class of modular biosensors that emit a bioluminescent signal when the sensor recognizes its target. Biosensors are...See details»
Technology - Monod Bio
The ground-breaking LuxSitâ„¢ Pro, de novo binders, and the biosensors that Monod Bio is developing are based on a dramatically expanded development space enabled by our AI-powered de novo protein design platform.See details»
Monod Bio Moving to New South Lake Union Space After $25M …
Aug 24, 2022 · Monod Bio, a spinout company from the University of Washington’s Institute for Protein Design, has raised $25M to develop molecular biosensors designed to detect …See details»
Institute for Protein Design spinout Monod Bio raises $25M for ...
The news: Monod Bio raised $25 million to develop molecular biosensors that light up when they bind their target. The sensors can be designed to detect molecules linked to disease and they …See details»
Monod Bio gets $25M for biosensors | C&EN Global Enterprise
Aug 22, 2022 · Monod Bio, a diagnostic biosensor company spun out of David Baker’s lab at the University of Washington Institute for Protein Design, has raised $25 million in seed funding.See details»
Institute for Protein Design spinout Monod Bio raises $25M for ...
Aug 15, 2022 · The news: Monod Bio raised $25 million to develop molecular biosensors that light up when they bind their target. The sensors can be designed to detect molecules linked to …See details»
Monod Bio Raises $25M To Quickly Diagnose Diseases
Aug 15, 2022 · Seattle-based biotech startup Monod Bio has raised $25 million in seed funding led by Matrix Capital to speed up disease detection.See details»
See How Monod Bio Raised $25 Million to Revolutionize …
Aug 23, 2022 · Monod Bio just raised $25 million in seed funding from investors like Matrix Capital. The company creates biosensors to diagnose diseases more efficiently than …See details»
Monod Bio Launches World's First Fully De Novo Protein Product ...
Jul 15, 2024 · Monod Bio is a spinout company from the University of Washington developing de novo protein-based products for the RUO and IVD commercial markets. The Company's …See details»
Biosensor Startup Monod Bio Raises $25M - GenomeWeb
Aug 15, 2022 · Monod is developing a biosensor platform that combines binding, transduction, and amplification in a single step to enable the detection of a variety of molecules including …See details»
News - Monod Bio
Monod Bio Launches World’s First Fully De Novo Protein Product: Luciferase LuxSitâ„¢ Pro for Life Sciences Research and DiagnosticsSee details»